Trademarkia Logo

Canada

C$
IDEFIRIX
REGISTERED

on 17 May 2023

Last Applicant/ Owned by

HANSA BIOPHARMA AB

P.O. Box 785SE-220 07 LUND

SE

Serial Number

2057829 filed on 9th Sept 2020

Registration Number

TMA1180038 registered on 17th May 2023

Registration expiry Date

9th Sept 2030

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

IDEFIRIX

Trademark usage description

pharmaceutical preparations for use in organ transplantation and for diagnosing, preventing, and treating cancer and autoimmune diseases; medicines fo Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in organ transplantation and for diagnosing, preventing, and treating cancer and autoimmune diseases; medicines for human and veterinary purposes, namely, medicine for use in organ transplantation and for preventing and treating cancer and autoimmune diseases; pharmaceutical preparations for elimination of antibodies for therapeutic purposes in immune related diseases and conditions; immunoglobulin-degrading enzymes for medical and veterinary purposes.


Classification kind code

11

Mark Details


Serial Number

2057829

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 4th Feb 2022
Search Recorded
Submitted for opposition 20
on 4th Feb 2022
Examiner's First Report
Submitted for opposition 223
on 4th Feb 2022
Total Provisional Refusal
Submitted for opposition 256
on 16th Aug 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 2th Dec 2020
Agent Changed
Submitted for opposition 257
on 15th Oct 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 15th Oct 2020
Formalized
Submitted for opposition 1
on 15th Oct 2020
Created
Submitted for opposition 228
on 9th Sept 2020
International Registration
Submitted for opposition 30
on 9th Sept 2020
Filed